Articles

Ekos for PE

Acute intermediate-risk pulmonary emboli (PE) in normotensive patients with right ventricle dysfunction present the clinician with a quandary. With a 3 percent mortality rate[1] — just shy of the...

May 27, 2014 — Ekos Corp. announced the U.S. Food and Drug Administration (FDA) has cleared the EkoSonic endovascular system for the ultrasound-facilitated, controlled and selective infusion...

May 16, 2014 — In a move to expand significantly its portfolio of solutions for peripheral interventions, Boston Scientific Corp. has entered into a definitive agreement to acquire the...

According to a new study, aspirating blood clots does not significantly reduce microvascular obstruction or reduce the risk of death in patients with non-ST-elevation myocardial infarction (NSTEMI...

ekos, pulmonary embolism, clot busting

Results of the ULTIMA trial using endovascular therapy to treat submassive pulmonary embolism (PE) were presented at the American College of Cardiology 2013 meeting, The trial is the first...

Specialists at Stony Brook Medicine’s Cerebrovascular and Stroke Center (CVC) are treating patients with a new generation of blood clot removal devices that show promise in successfully...

Bayer AngioJet DVT

Catheter-based thrombectomy systems are increasingly being used to remove blood clots from vessels inside the body, often as an adjunct therapy to systemic pharmaceutical thrombolytics. ...

January 16, 2013 — Rex Medical L.P. announced that it has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for the Cleaner15 Rotational Thrombectomy System.

August 30, 2012 — According to Millennium Research Group (MRG), an authority on the medical technology market, as significant numbers of peripheral vascular and vascular access procedures move out...

March 31, 2011 – Deep vein thrombosis, or DVT is more than just a one-time complication from a long plane ride. The Society of Interventional Radiology wants individuals to know the risk factors...